FREG.DE Turbo_OE 12/70/ DE000UK4V9V9 /
20/12/2024 19:41:03 | Var.-0.030 | Denaro21:54:12 | Lettera21:54:12 | Sottostante | Prezzo di esercizio | Expiration date | Tipo di opzione |
---|---|---|---|---|---|---|---|
1.230EUR | -2.38% | - Quantità in denaro: - |
- Quantità in lettera: - |
FRESENIUS SE+CO.KGAA... | 21.0135 EUR | 31/12/2078 | Call |
GlobeNewswire
24/04
Travere Therapeutics and CSL Vifor Announce European Commission Approves FILSPARI® (sparsentan) for ...
GlobeNewswire
23/04
Transferring Biomedical Research to Patients Faster: ForTra gGmbH Announces Positive Funding Track R...
GlobeNewswire
23/02
Travere Therapeutics and CSL Vifor Announce Sparsentan Receives Positive CHMP Opinion for the Treatm...
GlobeNewswire
04/09/2023
CIO Leadership: Generative AI and Visionary Leadership in the Enterprise Will Power the Discussion a...
GlobeNewswire
31/08/2023
CytoSorbents Granted Expanded ANVISA Registration to Treat Shock with CytoSorb in Brazil